A high dose of intravenous immunoglobulin increases CD94 expression on natural killer cells in women with recurrent spontaneous abortion

American Journal of Reproductive Immunology

Volumn 62, Issue 5, 2009, Pages 301-307

  Shimada, Shigeki ^a   Takeda, Masamitsu ^a   Nishihira, Jun ^b   Kaneuchi, Masanori ^a   Sakuragi, Noriaki ^a   Minakami, Hisanori ^a   Yamada, Hideto ^c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO INFORMATION UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD94; Immunoglobulin; Natural killer cell

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD94 ANTIGEN; IMMUNOGLOBULIN;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HUMAN; MACROPHAGE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPIC VARIATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MACROPHAGES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; PREGNANCY; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME;

EID: 70350391610     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00739.x     Document Type: Article

References (25)

1. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981, 1:1228-1231.
2. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982, 306:1254-1258.
3. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992, 326:107-116.
4. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001, 345:747-755.
5. Intravenous immunoglobulin in the prevention of recurrent miscarriage. Br J Obstet Gynaecol 1994, 101:1072-1077.
6. Christiansen OB, Mathiesen O, Husth M, Rasmussen KL, Ingerslev HJ, Lauritsen JG, Grunnet N. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin. Hum Reprod 1995, 10:2690-2695.
7. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995, 34:333-337.
8. Perino A, Vassiliadis A, Vucetich A, Colacurci N, Menato G, Cignitti M, Semprini AE. Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study. Hum Reprod 1997, 12:2388-2392.
9. Stephenson MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998, 39:82-88.
10. Jablonowska B, Selbing A, Palfi M, Ernerudh J, Kjellberg S, Lindton B. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Hum Reprod 1999, 14:838-841.
11. Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss. Fertil Steril 2006, 86(5 Suppl):S226-S227.
12. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2007, 114:134-142.
13. Yamada H, Kishida T, Kobayashi N, Kato EH, Hoshi N, Fujimoto S. Massive immunoglobulin treatment in women with four or more recurrent spontaneous primary abortions of unexplained aetiology. Hum Reprod 1998, 13:2620-2623.
14. Morikawa M, Yamada H, Kato EH, Shimada S, Kishi T, Yamada T, Kobashi G, Fujimoto S. Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: down-regulation of NK cell activity and subsets. Am J Reprod Immunol 2001, 46:399-404.
15. Takeda M, Yamada H, Iwabuchi K, Shimada S, Naito M, Sakuragi N, Minakami H, Onoé K. Administration of high-dose intact immunoglobulin has an anti-resorption effect in a mouse model of reproductive failure. Mol Hum Reprod 2007, 13:807-814.
16. Yamada H, Morikawa M, Furuta I, Kato EH, Shimada S, Iwabuchi K, Minakami H. Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003, 49:84-89.
17. Yamada H, Kato EH, Kobashi G, Ebina Y, Shimada S, Sakuragi S, Fujimoto S. High NK cell activity in early pregnancy correlates with subsequent abortion with normal chromosomes in women with recurrent miscarriage. Am J Reprod Immunol 2001, 46:132-136.
18. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003, 50:351-354.
19. Yamada H, Shimada S, Morikawa M, Iwabuchi K, Kishi R, Onoe K, Minakami H. Divergence of natural killer cell receptor and related molecule in the decidua from sporadic miscarriage with normal chromosome karyotype. Mol Hum Reprod 2005, 11:451-457.
20. Burshtyn DN, Long EO. Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell Biol 1997, 7:473-479.
21. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, Phillips JH, Lanier LL, Parham P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7:739-751.
22. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002, 14:615-621.
23. Dang Y, Heyborne KD. Cutting edge: regulation of uterine NKT cells by a fetal class I molecule other than CD1. J Immunol 2001, 166:3641-3644.
24. Tsuda H, Sakai M, Michimata T, Tanebe K, Hayakawa S, Saito S. Characterization of NKT cells in human peripheral blood and decidual lymphocytes. Am J Reprod Immunol 2001, 45:295-302.
25. van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 2007, 58:447-459.